Comparing the Two Top Stocks: Akebia Therapeutics, Inc. (NASDAQ:AKBA), Boeing Company (The) (NYSE:BA)

Akebia Therapeutics, Inc. (NASDAQ:AKBA)

Akebia Therapeutics, Inc. (NASDAQ:AKBA) closed at $4.27 on the last trading session with an increase of 1.43%, whereas, it previously closed at $4.21. The company has a market capitalization of $510.48 Million. The company traded shares of 521555 on the trading day while its three month average volume stands at 1.14 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) produced diluted EPS of -2.54. The EPS estimate for next year as estimated by analysts is at -0.64 while EPS for next quarter is estimated at -0.29. Earnings per Share growth for this year is reported at -46.1, while the analysts estimated the EPS growth for next year at -0.64% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 8.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Akebia Therapeutics, Inc. (NASDAQ:AKBA) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Akebia Therapeutics, Inc. (NASDAQ:AKBA) stands at 2.18 and Price to Book or P/B for the most recent quarter stands at 0.88. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Akebia Therapeutics, Inc. (NASDAQ:AKBA) are reported at 1.1 and 1.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Akebia Therapeutics, Inc. (NASDAQ:AKBA) stands at -28.5, -51 and -23 respectively

The trailing twelve month Revenue of Akebia Therapeutics, Inc. (NASDAQ:AKBA) is reported at 234.5 Million with income of -192600000. The outstanding shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) are 119.55 Million. The institutional Ownership of the shares of 72.4 stands at 0.80%, this figure is decreased -0.09 in the last six months. The insider ownership for the shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) is ticked at 1.4%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Akebia Therapeutics, Inc. (NASDAQ:AKBA) is the Mean Target Price estimated by the analysts which stands at 18.26. The 52 week high of Akebia Therapeutics, Inc. (NASDAQ:AKBA) is placed at 10.73 and 52 week low is standing at 4.08.

Performance wise the shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) rose up 3.89% for the week, it also fell -0.23% for the monthly performance, while for the quarter it went up -40.78%. The shares decrease -31.46% for the half year and plummeted for the Year-To-Date performance. The shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) shrinked -57.51% for the yearly performance.

Boeing Company (The) (NYSE:BA)

Boeing Company (The) (NYSE:BA) closed at $361.61 on the last trading session with an decrease of -1.02%, whereas, it previously closed at $365.33. The company has a market capitalization of $205.07 Billion. The company traded shares of 4.81 Million on the trading day while its three month average volume stands at 4.5 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Boeing Company (The) (NYSE:BA) produced diluted EPS of 17.48. The EPS estimate for next year as estimated by analysts is at 22.88 while EPS for next quarter is estimated at 1.76. Earnings per Share growth for this year is reported at 51.7, while the analysts estimated the EPS growth for next year at 22.88% and Earnings growth for next 5 years stands at 13.65% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 24.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Boeing Company (The) (NYSE:BA) is at 20.69 while the forward p/e is at 15.8. The P/S or Price to Sales ratio of Boeing Company (The) (NYSE:BA) stands at 2.04 and Price to Book or P/B for the most recent quarter stands at 1643.68. The Price to Free Cash Flow ratio or P/FCF is reported at 22.67. The quick ratio and the current ratio of Boeing Company (The) (NYSE:BA) are reported at 0.3 and 1.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Boeing Company (The) (NYSE:BA) stands at 8.7, 0 and 76.4 respectively

The trailing twelve month Revenue of Boeing Company (The) (NYSE:BA) is reported at 100.66 Billion with income of 10.13 Billion. The outstanding shares of Boeing Company (The) (NYSE:BA) are 567.1 Million. The institutional Ownership of the shares of 68.9 stands at 0.80%, this figure is increased 0.04 in the last six months. The insider ownership for the shares of Boeing Company (The) (NYSE:BA) is ticked at 0.1%, the figure is plummeted -11.3% in the last six months.

Some other important financial aspects to be discussed here for Boeing Company (The) (NYSE:BA) is the Mean Target Price estimated by the analysts which stands at 418.71. The 52 week high of Boeing Company (The) (NYSE:BA) is placed at 446.01 and 52 week low is standing at 292.47.

Performance wise the shares of Boeing Company (The) (NYSE:BA) rose up 2.99% for the week, it also rise 3.65% for the monthly performance, while for the quarter it went up -4.75%. The shares increase 2.47% for the half year and flew up for the Year-To-Date performance. The shares of Boeing Company (The) (NYSE:BA) grew 4.5% for the yearly performance.